Seeing Is Believing

Currently out of the existing stock ratings of Steve Byrne, 29 are a SELL (17.06%), 91 are a BUY (53.53%), 50 are a HOLD (29.41%).
Analyst Steve Byrne, currently employed at BAML, carries an average stock price target met ratio of 59.96% that have a potential upside of 24.88% achieved within 232 days.
Steve Byrne’s has documented 654 price targets and ratings displayed on 36 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare sectors.
Most recent stock forecast was given on APD, Air Products and Chemicals at 08-Jan-2026.
Analyst best performing recommendations are on INVA (INNOVIVA).
The best stock recommendation documented was for INVA (INNOVIVA) at 2/19/2015. The price target of $17 was fulfilled within 1 day with a profit of $0.68 (4.17%) receiving and performance score of 41.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-Jul-2024
$200
$10.49 (5.54%)
$95
9 days ago
(21-Jan-2026)
3/5 (60%)
$36.96 (22.67%)
113
Buy Since 16-Aug-2017
$207
$17.49 (9.23%)
$170
9 days ago
(21-Jan-2026)
10/18 (55.56%)
$43.96 (26.96%)
605
Hold Since 10-Jan-2024
$185
$-4.51 (-2.38%)
$125
17 days ago
(13-Jan-2026)
8/12 (66.67%)
$23.71 (14.70%)
187
Hold Since 07-Mar-2025
$156
$-33.51 (-17.68%)
$132
18 days ago
(12-Jan-2026)
28/33 (84.85%)
$-5.29 (-3.28%)
178
Hold Since 07-Jan-2026
$210
$20.49 (10.81%)
$113
23 days ago
(07-Jan-2026)
22/29 (75.86%)
$63.87 (43.71%)
336
Which stock is Steve Byrne is most bullish on?
Which stock is Steve Byrne is most reserved on?
What Year was the first public recommendation made by Steve Byrne?